Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.7
Price to sales ratio
21.37

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1301
RDNT
RadNet, Inc. - Common Stock
69.22 USD+3.62%+10.10%+0.77%-17.01%5.44 B USD
1345
SHC
Sotera Health Company - Common Stock
18.11 USD+0.67%+1.97%+1.00%+7.41%5.16 B USD
1844
NEOG
Neogen Corporation - Common Stock
11.81 USD-0.76%+30.21%+26.45%+125.81%2.58 B USD
1883
CDNA
CareDx, Inc. - Common Stock
47.09 USD-1.59%+31.65%+61.54%+215.83%2.44 B USD

Frequently asked questions about GRAIL, Inc. - Common Stock

What is the GRAIL, Inc. - Common Stock stock price today?

The current price of GRAIL, Inc. - Common Stock (GRAL) is 72.7. Over the past 24 hours, the stock has changed by +3.46%. Follow the GRAL chart for real-time price dynamics.

What is the stock ticker of GRAIL, Inc. - Common Stock?

GRAIL, Inc. - Common Stock trades under the ticker GRAL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is GRAIL, Inc. - Common Stock stock going up?

GRAL has changed by +13.54% over the last week, +5.71% over the last month, and -26.57% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of GRAIL, Inc. - Common Stock?

GRAIL, Inc. - Common Stock currently has a market capitalization of 3.12 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were GRAIL, Inc. - Common Stock earnings last quarter?

Last quarter, GRAIL, Inc. - Common Stock reported earnings of -2.29 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was GRAIL, Inc. - Common Stock revenue for the last quarter?

GRAIL, Inc. - Common Stock reported quarterly revenue of 40.78 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was GRAIL, Inc. - Common Stock net income for the last quarter?

GRAIL, Inc. - Common Stock reported net income of -93.19 M for the last quarter. The previous quarter showed -99.18 M, which means net income changed by +6.04%.

How many employees does GRAIL, Inc. - Common Stock have?

As of the latest available data, GRAIL, Inc. - Common Stock has 910 employees. Workforce size can provide additional context about the company's scale and operations.

What is GRAIL, Inc. - Common Stock EBITDA?

GRAIL, Inc. - Common Stock EBITDA is -98.08 M, and its EBITDA margin is -240.49%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy GRAIL, Inc. - Common Stock stock?

You can buy GRAIL, Inc. - Common Stock (GRAL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in GRAIL, Inc. - Common Stock stock?

Investing in GRAIL, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GRAL chart and related analysis on metatrader.com as part of your research.

GRAIL, Inc. - Common Stock

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021. In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.